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Abstract 
Background: Osteosarcoma is the most common malignancy of bone. Intratumoral hypoxia occurs in many solid 
tumors, where it is associated with the development of aggressive phenotype. ANRIL has been shown to be a long 
noncoding RNA that facilitates the progression of a number of malignancies. Yet, few studies have explored the 
expression pattern of ANRIL in osteosarcoma and the effect of hypoxia on ANRIL.
Methods: We evaluated the expression levels of ANRIL in osteosarcoma tissues, adjacent normal tissues and cells 
with quantitative real-time polymerase chain reaction. Multiple approaches including luciferase reporter assay with 
nucleotide substitutions, chromatin immunoprecipitation assay and electrophoretic mobility shift assay were used 
to confirm the direct binding of HIF-1α to the ANRIL promoter region. SiRNA-based knockdown and other molecular 
biology techniques were employed to measure the effect of HIF-1α on the expression of ANRIL.
Results: We found that the expression of ANRIL was upregulated in 15 pairs of osteosarcoma compared with adja-
cent normal tissues. We found that hypoxia is sufficient to upregulate ANRIL expression in osteosarcoma cells (MNNG 
and U2OS). HIF-1α directly binds to the putative hypoxia response element in the upstream region of ANRIL. What’s 
more, siRNA and small molecular inhibitors-mediated HIF-1α suppression attenuated ANRIL upregulation under 
hypoxic conditions. Upon hypoxia, ANRIL promoted cancer cell invasion and suppressed cell apoptosis.
Conclusion: Taken together, these data suggest that HIF-1α may contribute to the upregulation of ANRIL in osteosar-
coma under hypoxic conditions. ANRIL is involved in hypoxia-induced aggressive phenotype in osteosarcoma.
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Background
Osteosarcoma (OS) is a highly malignant tumor of bone 
that occurs mainly in the extremities of juvenile groups 
[1, 2]. The 5-year event-free survival rate (EFS) for 
patients diagnosed with localized disease has improved 
since the combined used of chemotherapy, radiotherapy 
and surgical ablation of the primary tumor. However, 
the 5-year survival rate of osteosarcoma patients with 
metastases is lower than 30  % [3, 4]. Accordingly, the 
leading cause of dismal outcomes in osteosarcoma is 
tumor metastasis. Thus, targeting osteosarcoma metas-
tasis may be a promising strategy in the treatment of 
human osteosarcoma. However, little progress has been 
made in this area as the molecular mechanisms underly-
ing osteosarcoma invasion and metastasis remain poorly 
understood.
Hypoxia have been shown to increase risks of inva-
sion, metastasis, treatment failure, and patient mortality 
in the majority of solid tumors, including osteosarcoma 
[5, 6]. The hypoxia inducible factor-1 (HIF-1) com-
plex plays a key role in mediating hypoxic response [7]. 
Open Access
Cancer Cell International
*Correspondence:  lihaoqing@medmail.com.cn; czd856@vip.163.com 
Department of Orthopaedics, Shanghai General Hospital, Shanghai 
Jiao Tong University School of Medicine, No 100 Hanning Road, 
Shanghai 200080, People’s Republic of China
Page 2 of 9Wei et al. Cancer Cell Int  (2016) 16:73 
HIF-1 is a heterodimeric transcription factor formed by 
HIF-1α and HIF-1β [8]. Previous studies have showed 
that hypoxia-inducible factor-1 alpha (HIF-1α), a tran-
scription factor that is stabilized under hypoxic condi-
tions, regulates the expression of multiple target genes 
by binding to the Hypoxia Responsive Elements (HREs, 
5′-RCGTG-3′) in their enhancers or promoters regions 
[9]. HIF-1α accumulation help cancer cells adapt to and 
survive in hypoxic conditions, leading to poor therapeu-
tic responses, decreased overall survival and disease-free 
survival in osteosarcoma patients [10–12]. Thus, it is vital 
to identify hypoxia-responsive genes for the development 
of effective treatments.
In addition to regulating protein-coding genes, includ-
ing but not limited to, vascular endothelial growth factor 
A (VEGFA), angiopoietin-like 4 (ANGPTL4), phospho-
glycerate kinase 1 (PGK1), hexose kinase 2 (HK2) and car-
bonic anhydrase IX (CAIX) [12], hypoxia/HIF-1α has been 
revealed to regulate the expression of miRNAs [13, 14]. 
Long noncoding RNAs are an important a subclass of non-
coding RNAs, which are longer than 200 nucletides (nts) in 
length and with little protein-coding potential. A growing 
volume of literature has confirmed the vital role that lncR-
NAs play in cancer biology [15–17]. However, the effect of 
hypoxia/HIF-1α on lncRNAs remains to be explored.
Long noncoding RNA ANRIL (CDKN2B antisense 
RNA 1) is transcribed as a 3.8-kb lncRNA in the oppo-
site direction from the INK4B-ARF-INK4A gene cluster 
[18]. ANRIL has been demonstrated to exert oncogenic 
activity in a variety of carcinomas [19–21]. The expres-
sion pattern of ANRIL in osteosarcoma tissues and in 
osteosarcoma cells under hypoxic conditions remain to 
be elucidated.
In the present study, we would like to explore the 
expression pattern and function of ANRIL in hypoxic 
osteosarcoma cells. We found that HIF-1α transcrip-
tionally activated ANRIL via directly binding to HREs 
in the upstream region of ANRIL upon hypoxia. The 
upregulation of ANRIL facilitated invasion of hypoxic 
osteosarcoma cells and inhibited cell apoptosis. Our data 
provides novel insights into the molecular mechanisms 
of how hypoxia/HIF-1α contributes to oncogenic pheno-
type of osteosarcoma and the involvement of ANRIL in 




A total of 15 osteosarcoma samples were collected 
postoperatively from patients who underwent surgical 
resection between 2006 and 2011 at the Department of 
Orthopedics, Shanghai Jiao Tong University Affiliated 
Sixth People’s Hospital (Shanghai, China). Informed 
consent was obtained from the patients enrolled in this 
study. The study was approved by the Ethics Committee 
of Shanghai Jiao Tong University (2015-DY-126).
Cell culture
The MNNG and U2OS cell lines were purchased from 
the ATCC. The cell lines were grown in Dulbecco’s Modi-
fied Eagle Medium (DMEM, Gibco BRL, Grand Island, 
NY, USA) supplemented with 10  % fetal bovine serum 
(FBS, HyClone, Camarillo, CA, USA) as well as 100  U/
ml penicillin and 100  μg/ml streptomycin (Invitrogen, 
Carlsbad, CA, USA). Cells were maintained in a humidi-
fied incubator at 37  °C in the presence of 5  % CO2. All 
cell lines have been passaged for fewer than 6  months. 
Hypoxia treatment (1 % O2, 5 % CO2, and 94 % N2) was 
performed in hypoxia Workstation (InVIVO2). The 
cells were incubated under hypoxic conditions for 24 h. 
HIF-1α specific inhibitor 3-(5′-hydroxymethyl-2′-furyl)-
1-benzylindazole (YC-1) was purchased from Sigma 
(Sigma Aldrich, St. Louis, MO, USA) and resolved in 
dimethyl sulfozide (DMSO). YC-1 treatment was used at 
a final concentration of 40  μM. YC-1 and equal volume 
of control (DMSO) were added into the culture medium 
12 h before hypoxia treatment.
RNA extraction and quantitative real‑time PCR
Total RNA was extracted from cancer cells utilizing the 
Trizol reagent (Invitrogen, Carlsbad, CA, USA) accord-
ing to the manufacturer’s instructions and quanti-
fied with Nanodrop 2000 (Thermo Fisher Scientific, 
Waltham, MA, USA). First-strand cDNA was generated 
with the Primer-Script™ one step RT-PCR kit (TaKaRa, 
Dalian, China). Quantitative real-time polymerase chain 
reaction (qRT-PCR) was performed with SYBR Green 
premix Ex Taq (TaKaRa) with β-actin as an internal con-
trol. MRNA values were normalized to that of β-actin. 
The relative expression of mRNA was calculated with 
the 2−ΔΔCt method. Each sample was repeated in trip-
licate. QRT-PCR data were analyzed and converted 
to relative fold changes. The primer sequences used 
in the present study were as the followings: ANRIL, 
5 ′-TTGTGAAG CCC AAGTAC TG C-3 ′ ( for ward) , 
5′-TTCACTGTGGAGACGTTGGT-3′(reverse); HIF-1α, 
5 ′-CATCTCCATCTCCTACCCACA-3 ′(for ward), 
5′-CTTTTCTGCTCTGTTTGGTG-3′(reverse); GAPDH, 
5 ′-AGAAGGCTGGGGCTCATTTG-3 ′(for ward), 
5′-AGGGGCCATCCACAGTCTTC-3′(reverse); β-actin, 
5 ′-CTGGGACGACATGGAGAAAA-3 ′(for ward), 
5′-AAGGAAGGCTGGAAGAGTGC-3′(reverse).
Western blot analysis
Cell lysates were extracted from cultured cells with RIPA 
buffer (Cell Signaling Technology) supplemented with 
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the protease inhibitors. The lysates were subjected to 
ultrasonication and centrifugation. The protein concen-
trations were determined with the BCA Protein Assay 
Kit (Pierce). Equal amounts (30–40 μg) of proteins sam-
ples were separated by 8–12 % SDS–polyacrylamide gel 
electrophoresis and then transferred onto a nitrocel-
lulose filter membranes (Millipore). After blocking in 
phosphate-buffered saline/Tween-20 containing 5  % 
non-fat milk, the membrane was immunoprecipitated 
with indicated primary antibodies overnight at 4  °C: 
rabbit polyclonal anti-human HIF-1α antibody (1:1000, 
Abcam), rabbit polyclonal anti-human Bcl-2 antibody 
(1:500, Abcam), rabbit polyclonal anti-human Bax anti-
body (1:500, Abcam), and rabbit polyclonal anti-human 
β-actin antibody (1:1000, Abcam). The membranes were 
washed with TBST (3 ×  5  min), and then immunopre-
cipitated with the secondary antibody [HRP-conjugated 
goat anti-rabbit IgG antibody (Abcam)] for 1 h at room 
temperature. Subsequent visualization was detected with 
SuperSignal West Femto Maximum Sensitivity Substrate 
(Thermo Fisher Scientific). Intensities of the bands were 
normalized to the corresponding β-actin bands.
Plasmid construction
The ANRIL promoter constructs were generated using 
PCR-based amplification with human genomic DNA as 
the template and was subcloned in the pGL3 basic fire-
fly luciferase reporter. The HRE mutations were created 
using a Quick-change Multi Site-Directed Mutagenesis 
Kit (Stratagene, La Jolla, CA, USA) with ANRIL pro-
moter plasmid as the template. The primers for Site-





ANRIL specific siRNA, HIF-1α siRNA and Allstars 
Negative Control siRNA were purchased from Biotend 
(Shanghai, China). HIF-1α siRNA, 5′-CCGCTGGAGA 
CACAATCATAT-3′; ANRIL siRNA-1, 5′-GGUCAUC 
UCAUUGCUCUAU-3′; ANRIL siRNA-2, 5′-AAAUCC 
AGAACCCUCUGACAUUUGC-3′; siRNA control, 
5′-UUCUCCGAACGUGUCACGUTT-3′. Vector were 
transfected into cells by Lipofectamine-mediated gene 
transfer according to the manufacturer’s protocol. For 
RNA extraction and western blotting assays, cells were 
used 48 h after transfection.
Luciferase reporter assay
HIF-1α siRNA and the ANRIL promoter/luciferase 
reporter construct were cotransfected into osteosarcoma 
cells by Lipofectamine 2000-mediated gene transfer. 
Each sample was cotransfected with the pRL-TK plas-
mid in order to monitor transfection efficiency (Promega, 
Madison, WI, USA). Luciferase assays were carried out 
utilizing the dual-luciferase reporter assay system kit 
(Promega). The luciferase expression was measured with 
Modulus single-tube multimode reader (Promega). The 
relative luciferase activity was normalized to the renilla 
luciferase activity.
Electrophoretic mobility shift assay (EMSA)
OSTEOSARCOMA cells were incubated under hypoxic 
conditions for 24  h. EMSA was carried out utilizing a 
light shift chemiluminescent EMSA kit (Pierce). Nuclear 
proteins from OSTEOSARCOMA cells were prepared 
using NE-PER nuclear and cytoplasmic extraction rea-
gents (Pierce, Rockford, IL, USA). Nuclear proteins (4 μg) 
were incubated with binding buffer [2.5 % glycerol, 5 mM 
MgCl2, 0.05  % NP-40, 1  μg poly(dI–dC), 10  mM Tris, 
50 mM KCl, 1 mM DTT, pH 7.5] with or without of 200-
fold (3  pmol) unlabeled probes (cold probe or mutant 
probe) for 20  min, followed by the incubation with the 
biotin labeled probes (10 fmol) for 20  min. Samples 
were electrophoresed on a 6  % polyacrylamide gel. The 
probes used were as the followings: HRE probe, 5′-AATG 
TATCACACGCCATCTGGG-3′; HRE mutant probe, 
5′-CGAGCGCAGTGGCATGGGGCTGTAATCCCA-3′.
Chromatin immunoprecipitation (ChIP) assay
Chromatin immunoprecipitation (ChIP) assays were 
carried out using the EZ ChIP Chromatin Immunopre-
cipitation Kit (Millipore, Bedford, MA, USA) accord-
ing to the manufacturer’s protocol. Briefly, Chromatin 
was sonicated on ice to an average length of 200–300 bp 
in an ultrasound bath. Human IgG was employed as 
the negative control. Chromatin was immunoprecipi-
tated with rabbit polyclonal anti-human HIF-1α anti-
body (Abcam, Cambridge, MA, USA). ChIP-derived 
DNA was quantified using qRT-PCR. Quantitative 
PCR reactions were then performed on real-time PCR 




Cell viability assays were performed utilizing the CCK-8 
assay kits following by the manufacturer’s protocol. Cells 
transfected with desired vector were seeded into the 
96-well plates at an initial density of 5000 cells/well and 
cultured under hypoxic conditions. At the indicated time 
points, CCK-8 solution 10  µl was added into each well 
and incubated for 2  h. The absorbance was determined 
by scanning at 450  nm with a microplate reader. Data 
were presented as the percentage of viable cells as the fol-




Cells transfected with desired vector were seeded into the 
6-well plates and cultured under hypoxic conditions for 
48 h. The cultures were then stained with annexin V-FITC 
and propidium iodide (Beyotime, Haimen, China) follow-
ing the manufacture’s instructions and examined using a 
flow cytometer (Becton–Dickinson, USA).
Cell invasion assay
Cells transfected with desired vector (2 ×  105 in 100 µl 
serum-free medium) were seeded in the upper chamber 
of an insert (8.0 µm, Millipore, MA). The insert was pre-
coated with Matrigel (Sigma, USA). The lower chamber 
was added with 400 µl of culture medium supplemented 
with 10  % FBS for 24  h hypoxia treatment before final 
examination. The cells on the upper surface that didn’t 
invade were wiped off with a cotton swab, whereas cells 
on the lower membrane surface were fixed with metha-
nol for 15 min and stained with 0.01 % crystal violet in 
PBS for 10  min. Cells from three random fields were 
counted under a phase contrast microscope (original 
magnification, ×200) and the relative number was deter-
mined. Experiments were repeated in triplicate.
Statistical analysis
All statistical analyses were performed using SPSS 
17.0 (SPSS, Chicago, USA). All data were presented as 
mean ±  standard error from three independent experi-
ments. Statistical evaluations were analyzed with inde-
pendent student’s t test unless otherwise indicated. A 
two-sided P value less than 0.05 was considered to be sta-
tistically significant.
Results
Hypoxia transcriptionally activated ANRIL in osteosarcoma 
cells
To start with, we examined the expression pattern of 
ANRIL in osteosarcoma tissues. According to the results 
of qRT-PCR, the expression levels of ANRIL were sig-
nificantly higher in osteosarcoma tissues compared with 
adjacent normal tissues (n =  15, P  <  0.001; Fig.  1a). As 
ANRIL was frequently upregulated in osteosarcoma, we 
would like to determine the transcriptional factors that 
contributed to its upregulation. In the first place, we 
examined the effect of hypoxia on the expression level 
of ANRILA. Hypoxia obviously increased the transcript 
levels of ANRIL in MNNG and U2OS cells (Fig.  1b). 
Meanwhile, hypoxia markedly enhanced the promoter 
activities of ANRIL (Fig.  1c). Together, it suggests that 
hypoxia promoted the transcriptional activity and 
expression level of ANRIL in osteosarcoma cells.
HIF‑1α directly binds to hypoxia responsive elements 
(HREs) of the ANRIL promoter region under hypoxic 
conditions
We sought to investigate whether HIF-1α took a part 
in upregulating the expression level of ANRIL under 
hypoxic conditions. We identified one putative binding 
site for HIF-1 (HRE, −714 to −705 bp) in the upstream 
region of ANRIL with online bioinformatical software 
programs MatInspector (http://www.genomatix.de/
online_help/help_matinspector/matinspector_help.html) 
(Fig.  2a). We detected the expression of HIF-1α under 
normoxic and hypoxia conditions. Western blotting 
analysis demonstrated that hypoxia obviously upregu-
lated the protein levels of HIF-1α, whereas hypoxia had 
no effects on the mRNA levels of HIF-1α (Fig. 2b, c). The 
direct interaction between HIF-1α and putative HRE was 
Fig. 1 Hypoxia upregulates ANRIL expression in osteosarcoma cells. a Expression level of ANRIL by qRT-PCR in 15 osteosarcoma tissues and paired 
non-tumor tissues. GAPDH was used as a loading control. b ANRIL expression under both normoxic and hypoxic conditions were analyzed by real-
time PCR. c ANRIL promoter activity under both normoxic and hypoxic conditions were analyzed by luciferase assay (**, P < 0.01, n = 3). β-actin was 
used as the internal control (**, P < 0.01, n = 3)
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confirmed with the EMSA assay (Fig. 2d). Furthermore, 
HIF-1α immunoprecipitates were highly enriched in the 
DNA fragments compared with negative control IgG 
immunoprecipitates in the ChIP assay (Fig. 2e). Together, 
it suggests that HIF-1α directly binds to hypoxia respon-
sive elements (HREs) of the ANRIL promoter region 
upon hypoxia in both MNNG and U2OS cells.
HIF‑1α potently induces ANRIL expression in osteosarcoma 
cells upon hypoxia
To explore whether HIF-1α transcriptionally activates 
ANRIL expression in osteosarcoma cells under hypoxic 
conditions, we constructed the wild and mutant type 
of HRE in the promoter region of ANRIL. A significant 
reduction in the ANRIL promoter activity was observed 
when we mutated the putative HREs in both MNNG 
and U2OS cells upon hypoxia (Fig.  3a). A HIF-1α spe-
cific siRNA was transfected in MNNG and U2OS cells to 
suppress HIF-1α expression under hypoxic conditions. 
HIF-1α specific siRNA potently decreased the mRNA 
and protein levels of HIF-1α (Fig.  3b, c). Meanwhile, 
HIF-1α specific siRNA significantly reduced the pro-
moter activities (Fig. 3d) and transcript levels (Fig. 3e) of 
ANRIL in both MNNG and U2OS cells. In the meantime, 
HIF-1α-specific inhibitor YC-1 significantly reduced the 
mRNA (Fig.  3f ) and protein levels (Fig.  3g) of HIF-1α 
Fig. 2 HIF-1α binds to hypoxia responsive elements of the ANRIL promoter under hypoxic conditions. a Schematic representation of the putative 
binding sites of hypoxia responsive elements (HREs) in the ANRIL promoter. b HIF-1α mRNA levels under both normoxic and hypoxic conditions 
(24 h) were analyzed by real-time PCR. β-actin was used as the internal control. c HIF-1α protein levels under both normoxic and hypoxic condi-
tions were analyzed by Western blotting. β-actin was used as the internal control (**, P < 0.01, n = 3). d EMSA showed the interaction of HIF-1α with 
the ANRIL promoter in vitro. e ChIP showed the interaction of HIF- 1α with the ANRIL promoter. The HIF-1α antibody effectively enriched the DNA 
sequence covering the putative binding element. Normal rabbit IgG was used as a negative control, and an anti-HIF-1α polymerase antibody was 
used as a positive control. Sonicated DNA fragments were used as input
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under hypoxic conditions. YC-1 also ameliorated the 
upregulation of ANRIL in hypoxic osteosarcoma cells 
(Fig.  3h). Collectively, these data showed that HIF-1α 
could transcriptionally activate ANRIL in hypoxic osteo-
sarcoma cells.
Effects of ANRIL silencing on viability and apoptosis 
of hypoxic osteosarcoma cells
To investigate the biological effects of ANRIL under 
hypoxic conditions, we transfected U2OS cells with the 
most efficient ANRIL specific siRNA that have been con-
firmed in other studies [19]. The hypoxia-induced ANRIL 
expression was knocked down by ANRIL specific siR-
NAs (Fig. 4a). ANRIL silencing reduced the hypoxic cell 
viability compared to the negative control cells (Fig. 4b). 
Furthermore, ANRIL silencing increased the apopto-
sis rate of U2OS cells compared to the negative control 
cells under hypoxic conditions (Fig. 4c). ANRIL-knocked 
down cells demonstrated increased Bax/Bcl-2 ratio 
under hypoxic conditions (Fig. 4d). Thus, it indicates that 
ANRIL increases cell viability and inhibits apoptosis of 
osteosarcoma cells under hypoxic conditions.
ANRIL silencing attenuated hypoxia‑induced invasion 
in osteosarcoma cells
In the functional aspect, we investigated the effects 
of ANRIL on invasive capacity of osteosarcoma cells. 
Hypoxia significantly increased the invasive potencies of 
U2OS cells (Fig. 5a, b). However, such as effect was atten-
uate by ANRIL silencing (Fig. 5a, b). These data suggest 
Fig. 3 HIF-1α enhances ANRIL expression in osteosarcoma cells. a Osteosarcoma cells were transfected with HRE-mutant ANRIL promoter con-
structs. ANRIL promoter activity was detected by luciferase assay (**, P < 0.01, n = 3). b HIF-1α mRNA levels were analyzed by real-time PCR after 
siRNA knockdown of HIF-1α. β-actin was used as an internal control (**, P < 0.01, n = 3). c HIF-1α protein levels were analyzed by Western blotting 
after HIF-1α knockdown. β-actin was used as the internal control. (**, P < 0.01, n = 3). d Effect of HIF-1α silencing on ANRIL promoter activity was 
detected by luciferase assay (**, P < 0.01, n = 3). e Effect of HIF-1α silencing on ANRIL expression was detected by real-time PCR. β-actin was used 
as an internal control (**, P < 0.01, n = 3). f HIF-1α mRNA levels were analyzed by real-time PCR after treatment with YC-1 HIF-1α-specific inhibitor 
(40 μM). β-actin was used as an internal control (**, P < 0.01, n = 3). g HIF-1α protein levels were analyzed by Western blotting after treatment with 
YC-1 (40 μM). β-actin was used as the internal control (**, P < 0.01, n = 3). h Effect of YC- 1 on ANRIL expression was detected by real-time PCR. 
β-actin was used as an internal control (**, P < 0.01, n = 3)
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that ANRIL is involved in hypoxia-mediated invasion of 
osteosarcoma cells.
Discussion
It has been well recognized that hypoxia results in the 
transformation of cancer cells into more aggressive phe-
notypes through the regulation of oncogenes that pro-
mote the progression and metastasis of cancer [5–7]. 
However, whether lncRNA is involved in such a process 
remains largely elusive. The present study characterized 
ANRIL as a hypoxia-inducible lncRNA that is important 
for the hypoxia-mediated aggressive phenotype.
Long noncoding RNA ANRIL (CDKN2B antisense 
RNA 1) is transcribed as a 3.8-kb lncRNA in the oppo-
site direction from the INK4B-ARF-INK4A gene cluster 
[18]. ANRIL has been demonstrated to exert oncogenic 
activity in a variety of carcinomas [19, 20]. Yet, few stud-
ies have focused on the transcriptional factors that con-
tributed to its upregulation. Wan et al. [21] demonstrated 
that ANRIL, is transcriptionally up-regulated by the 
Fig. 4 Effects of ANRIL silencing on the viability and apoptosis of hypoxic osteosarcoma cells. a Knockdown efficiency of ANRIL siRNA was detected 
by real-time PCR. β-actin was used as the internal control (**, P < 0.01, n = 3). b Cell viability of ANRIL-silenced and negative control U2OS cells 
cultured under hypoxic conditions was detected by CCK-8 assay. Data are presented as a percentage of the control group (**, P < 0.01, n = 3).  
c Apoptosis of ANRIL-silenced U2OS cells and negative control cells under hypoxia conditions was measured by flow cytometry (**, P < 0.01, n = 3). 
d Bax and Bcl-2 protein levels were analyzed by Western blotting after ANRIL knockdown. β-actin was used as the internal control. (**, P < 0.01, 
n = 3). Data represent the mean ± S.D
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transcription factor E2F1 in an ATM-dependent manner 
following DNA damage. In this study, we proposed a link 
between hypoxia and ANRIL, which are two well-known 
mediators of malignancy.
In this study, we investigated the expression pat-
tern of ANRIL in osteosarcoma cells under normoxic 
and hypoxic conditions. Hypoxia increased the tran-
scriptional activity and expression level of ANRIL in 
osteosarcoma cells. We then explored the underlying 
molecular mechanism that contributed to the upregula-
tion of ANRIL under hypoxic conditions. We revealed 
that HIF-1α directly binds to the HREs in the ANRIL 
promoter region and induced ANRIL expression. HIF-1α 
knockdown and inhibition blunted the hypoxia-depend-
ent transcriptional activation. HIF-1α silencing abrogated 
hypoxia-induced invasive capacity in osteosarcoma cells.
Apart from ANRIL, which is induced by hypoxia, 
previous reports have also characterized several other 
lncRNAs as hypoxia-responsive lncRNAs, such as lin-
cRNA-p21 [8], LET [15], NEAT1 [22] and linc-ROR 
[23], which can be regulated by hypoxia and are involved 
in hypoxia-induced signaling transduction in cancer. 
These studies, in addition to the present study, suggest 
that lncRNAs may also play a role in hypoxia-induced 
signaling.
Hypoxia readily occurs in most solid tumors, and 
HIF-1α is upregulated in most human cancers, including 
osteosarcoma [10–12]. HIF-1α upregulation is associated 
with tumor metastases and dismal prognosis [12–14]. 
HIF-1α facilitated tumorigenesis by activating target 
genes that are involved in a wide array of cellular pro-
cesses [12]. Thus, our study expanded the category of the 
downstream effectors of HIF-1α.
We revealed that ANRIL is a HIF-1α-inducible lncRNA 
and is involved in hypoxia-induced aggressive pheno-
type in osteosarcoma. It suggests that the HIF-1α—
ANRIL pathway may be a potential therapeutic target for 
osteosarcoma.
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